Hangzhou Hebei Technology Co., Ltd., established in 2009, is a national high-tech enterprise specializing in the R & D and service of biomedical science and technology. With a registered capital of 10 million yuan, the company is a leading professional third-party life medicine research service enterprise in Zhejiang Province. After years of development, the company has established branches and offices in many places, sales network throughout the country, with comprehensive advanced technology, good quality management system and satisfactory customer tracking service system, enjoys a high reputation in the industry. The company has a first-class technical management team mainly composed of senior researchers. More than 90% of the company's scientific research personnel, including those who have returned from overseas, have master's and doctor's degrees. At present, the company has established strategic cooperative relations with many universities, scientific research institutes and pharmaceutical enterprises at home and abroad, and has carried out all-round cooperation in the fields of scientific research and technical services, pharmaceutical product research and development, etc.
In 2014, the company established the ISO 17025 "General requirements for the ability of testing and calibration laboratories" quality management system. After more than one year of comprehensive operation, Hangzhou Hebei Technology Co., Ltd. finally ushered in the China National Accreditation Service for conformity assessment, CNAs) appointed experts for on-site review, and awarded CNAs certificate on October 13, 2016. It marks that the technical capabilities and experimental reports of some laboratories of Hebe science and technology have been recognized by more than 40 national and regional laboratory accreditation institutions under the mutual recognition agreement. It is the first enterprise in the Yangtze River Delta to have a third-party scientific research laboratory which has passed the ISO 17025 quality management system certification and CNAs accreditation.
The company's two main businesses: It is specialized in medical research services, with eight scientific research technology platforms covering animal models of diseases, molecular biology, cell biology, pathology, imaging, microbiology, analytical chemistry, and medical nano materials customization. We are specialized in preclinical research services, providing customized preclinical experimental service programs for customers. We have accumulated many years of technical experience, and provide professional one-stop service in drug screening, efficacy evaluation, safety evaluation, pharmacokinetics, etc. To provide you with high-quality data to support drug development, preclinical research and clinical research. At the same time, the company also has rich practical experience in the R & D services of medical devices, food, health products, stem cell therapy and other projects.